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The contribution of smooth muscle cells as a
potential source of eicosanoid production during
in￿ ammatory states remains to be elucidated. We
investigated the effect of trinitrobenzene sulfonic
acid (TNB), a known pro-in￿ ammatory agent, on
jejunal smooth muscle cell eicosanoid produc-
tion. Human gut-derived smooth muscle cells
(HISM) were incubated with TNB for 1 hour.
Additionally, some cells were preincubated with
either dimethylthiourea, or indomethacin for 1
hour before exposure to identical concentrations
of TNB. Incubation with TNB led to signi￿ cant
increases in PGE2 and 6-keto PGF-1a release, but
not leukotriene B4 release; responses which were
both inhibited by dimethylthiourea and indo-
methacin treatment. Our results suggest that gut-
derived smooth muscle cells may represent an
important source of proin￿ ammatory prosta-
noids but not leukotrienes during in￿ ammatory
states of the intestine. The inhibition of prosta-
noid activity by thiourea may be mediated by
suppression of cyclooxygenase activity in this cell
line.
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Introduction
In￿ammatory bowel diseases, including Crohn’s
disease and ulcerative colitis, are multifactorial
disorders whose etiology remains poorly under-
stood. They are characterized by either muco-
sal or transmural necrosis that produces
symptoms of crampy abdominal pain, diarrhea,
and failure to thrive. A number of mediators of
in￿ammation such as reactive oxygen metabo-
lites, neutrophils, autacoids, cell adhesion mo-
lecules, and cytokines have been implicated as
contributors to the cellular events leading to
intestinal in￿ammation. In both experimental
models of colitis and in tissue and rectal
dialysates from patients with colitis, elevated
levels of mucosal prostanoids, leukotrienes and
cytokines have been observed.1 With the pre-
mis that these mediators of in￿ammation may
perpetuate illness, much effort has been direc-
ted towards the amelioration of these re-
sponses through the application and use of
cyclooxygenase inhibitors and cytokine antago-
nists.
The effects of intestinal in￿ammation on
gastrointestinal motility in terms of the produc-
tion and effect of prostaglandins, thrombo-
xanes, and leukotrienes has prompted a search
for their physiologic role in these processes.
The effects of eicosanoids on gastrointestinal
motility has been studied both in vitro using
isolated segments of esophagus, stomach, ileum
and colon and in vivo following intravenous
infusion into animals and man. There is ample
evidence that eicosanoids may be involved in
complex interactions that govern the control of
contraction of gastrointestinal smooth muscle,
as well as the promotion of in￿ammatory
responses. It is important to point out, how-
ever, that their effects show considerable vari-
ability depending on the type of eicosanoid,
the dose, the species studied and the muscle
layer which is used.2 Certainly, in patients with
intestinal in￿ammatory disorders both diarrhea
and ileus are present. The role of prostanoids
as potential contributors to these responses
remains to be further elucidated.
Reactive oxygen intermediates or oxygen
derived free radicals such as superoxide and
hydroxy radicals have been shown to induce
cyclooxygenase (COX) activity. Thiourea com-
pounds (i.e. DMTU), which are free radical
scavengers, have been shown to exhibit potent
gastroprotective properties against a variety of
luminal insults, suggesting that they may pos-
sess anti-in￿ammatory properties.3,4 To date,
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tion during intestinal in￿ammatory states have
not been thoroughly delineated, although there
has been some suggestion that they modulate
prostanoid production under both in vivo and
in vitro conditions.3- 6
Cell cultures from isolated smooth muscle
cells have become invaluable for the study of
fundamental physiologic and biochemical prop-
erties of muscle. Most studies have focused on
contractile properties of smooth muscle cells
in culture, while their role as potential con-
tributors to eicosanoid production has been
underscored. Previous studies have documen-
ted that colitis can be induced by the adminis-
tration of an enema containing the contact
sensitizing allergen TNB in ethanol; these
chemicals have also been utilized in rabbits to
produce ileitis. The present study was under-
taken to investigate the effect of TNB on
release of prostanoids and leukotrienes by a
human small intestinal smooth muscle cell line
and the subsequent impact of dimethylthiourea
on TNB-induced eicosanoid release.
Methods
Human intestinal smooth muscle cells (HISM,
catalogue # 1692-CRL) were obtained from the
American Type Culture Collection (Rockville,
MD). Cells were maintained at 378 C in an
atmosphere of 5% CO2 and 100% relative
humidity. Cells were split at a ratio of 1:2 upon
reaching con￿uency. Cells were detached using
0.5 g porcine trypsin and 0.2 g tetrasodium
EDTA/l Hank’s balanced salt solution (Sigma
Chemical, St. Louis, MO) and then plated
into 24-well plates, for experiments, or into
175-cm2 ￿asks (Costar, Cambridge, MA) for
propogation. Media was changed every 5±7
days; Dulbecco’s modi￿ed Eagle’s medium with
10% fetal bovine serum, 100 units/ml peni-
cillin, 100 mg/ml streptomycin and 0·25 mg/ml
amphotercin B (Sigma) was used. The cells
were plated at a seeding density of 2 3
105 cells/well and allowed to grow to con￿u-
ence. Viability of the cells was veri￿ed by
trypan blue exclusion and morphology was
evaluated by phase contrast microscopy.
Stock solutions of TNB (1 mM; Sigmal Chemi-
cals, St. Louis, MO) and dimethythiourea
(DMTU, 5 mM; Sigma Chemicals, St. Louis,
MO) were diluted in Krebs±Ringer’s bicarbo-
nate. Indomethacin (Indo, 5 mM; Sigma Chemi-
cals. St. Louis, MO) was dissolved in 5 mg/ml
Na2CO3 in physiological saline. Cells were
preincubated with Indo (40 mM) or DMTU
(50 mM) for 1 hour in serum free media.
Control cells were exposed to serum free
media alone. All cells were then incubated
with TNB (10 mM) for an additional 1 hour
period. At the conclusion of the experiments,
the cells and buffer were collected and frozen
at - 808 C until use.
PGE2, 6 keto-PGF1a and LTB4 assays were
performed in duplicate without separation by a
competitive enzyme assay which uses an ace-
tylcholinesterase tracer (Cayman, Ann Arbor,
MI). The eicosanoid concentrations were deter-
mined by spectrophotometric analysis after
addition of Ellman’s reagent and compared to
standard curves generated under identical con-
ditions.
Total protein concentration was estimated
colorometrically with BCA protein assay kits
(Pierce, Rockford, IL). Brie￿y, the plates were
thawed and cells incubated and permeabilized
in 0·3 ml of 1 N NaOH. All samples were then
incubated at 378 C for 30 min and 50 ml aliquots
of blank, BSA standard or sample were mixed
with 200 ml of test reagent and loaded into 96-
well plates. After a 2 hour incubation period at
378 C, all samples were read in a spectrophoto-
metric plate reader at a wavelength of 595 nm.
The concentrations of eicosanoids were ex-
pressed as pg/mg total protein. The data is
presented as mean SEM. Statistical analysis
was performed by analysis of variance. Differ-
ences between groups was determined by the
least signi￿cant difference. ‘Signi￿cant’ indi-
cates P, 0·05.
Results
Incubation of HISM cells with TNB produced
signi￿cant and dose-dependent increases in the
release of PGE2 and 6-KPGF1a (the stable
metabolite of prostacyclin). TNB administration
in the concentrations and time intervals used
in this study did not signi￿cantly change LTB4
production by these cells. Similarly, preincuba-
tion of HISMcells with DMTUor indomethacin
had no effect on LTB4 levels.
Preincubation of these cells with either
indomethacin or DMTU signi￿cantly decreased
both basal and TNB stimulated PGE2 and 6-
KPGF1a release, suggesting that DMTU, like
indomethacin, may have a direct inhibitory
effect on smooth muscle prostaglandin release
(T able 1).
Discussion
Arachidonic acid metabolites play pivotal, but
complicated and often contradictory, roles in a
wide range of normal autocrine and paracrine
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tors in intestinal in￿ammation has been
studied both in vivo and in vitro conditions
in which increased levels of arachidonic
acid metabolites have been demonstrated. In
a previous study PGE2 and prostacyclin release
were noted when CaCO2 cells were exposed
to the Clostridium dif￿cile toxin, a known
pro-in￿ammatory agent.7 Interestingly, pretreat-
ment of these cells with indomethacin, a
commonly employed cyclooxygenase inhibitor
before exposure to this toxin resulted in an
inhibitory effect on PGE2 and 6-KPGF1a but
a paradoxical increase in LTB4 release. Further
investigations using a similar model of TNB-
induced stimulation demonstrated increased
release of PGE2 and 6-KPGF1a which corre-
lated with elevated release of lactate dehydro-
genase, con￿rming signi￿cant cellular injury
under these conditions. Indomethacin pretreat-
ment attenuated markedly the elevations in
prostanoid release.8
Free radicals such as the superoxide anion,
the hydroxy radical and nitric oxide are gener-
ated at sites of in￿ammation. These highly
reactive chemical species have been shown to
induce COX-2 activity. Inhibitors of reactive
oxygen formation and the scavengers of reac-
tive oxygen species have been reported to
block prostanoid production by quenching the
generation of hydroperoxides, which are activa-
tors of COX.9 In rat mesangial cells, following
in￿ammatory stimuli or growth factors, thiour-
eas inhibited the increase in COX-2 mRNA,
COX-2 protein and PGE2 synthesis.10 This
proposed mechanism of transcription of the
COX-2 gene may operate through the NFkB
transcription factor.11 The relationship between
nitric oxide and COX is unclear. Nitric oxide,
another free radical associated with in￿amma-
tion, has been demonstrated to potentiate
prostaglandin output in endothelial cells by
activation of COX.12 On the other hand, inhibi-
tion of prostaglandin release by nitric oxide
has been observed in macrophages.13
Prostanoids act locally in a paracrine and
autocrine manner and modulate cell and tissue
responses in physiological and pathological
states. Most whole organ models of intestinal
in￿ammation focus on the role of epithelial
cells as a major potential source of pro-in￿am-
matory prostanoids, whereas a contributory
role for enhanced eicosanoid synthesis by the
underlying smooth muscle cell is often over-
looked. Intestinal smooth muscle cells produce
eicosanoids as well and serve as a potential
source for these important in￿ammatory media-
tors. Our data demonstrates that: intestinal
smooth muscle cells represent a potential
source of pro-in￿ammatory prostanoids de-
tected in this model of intestinal in￿ammation;
and that thioureas such as DMTU inhibit the
release of these endogeneous smooth muscle
prostanoids in a manner similar to the activity
of another cyclooxygenase inhibitor ± indo-
methacin. Based upon the effect of DMTU on
eicosanoid production, a novel suggestion from
the present study is that thioureas may provide
a potential new clinical modality for the treat-
ment of intestinal in￿ammatory states.
This study suggests that human smooth
muscle cells produce oxygen free radicals in
response to TNB and the effect of the reactive
oxygen species is attentuated by the anti-
oxidant. Alternatively, dimethylthiourea may
inhibit the prostanoid formation through a
mechanism independent of the neutralization
of oxygen free radicals. Further studies are
underway to attempt to answer this question.
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